Modified Thrombolytic Therapy for Massive Pulmonary Emboli - 25/07/11
Doi : 10.1016/j.amjmed.2011.02.031
Reza Arsanjani, MD a, Steven Goldman, MD a, Michael P. Habib, MD b, Mohammad Reza Movahed, MD, PhD a, ⁎ 
a Department of Medicine, Division of Cardiology, The Southern Arizona VA Health Care System and The University of Arizona Sarver Heart Center, Tucson
b Department of Medicine, Division of Pulmonary Medicine, The Southern Arizona VA Health Care System, Tucson
Requests for reprints should be addressed to M. Reza Movahed, MD, PhD, Heart Transplant Program, Department of Medicine, Division of Cardiology, The Southern Arizona VA Health Care System, The University of Arizona Sarver Heart Center, 1501 North Campbell Ave., Tucson, AZ 85724
Le texte complet de cet article est disponible en PDF.
Plan
| Funding: None. |
|
| Conflict of Interest: None of the authors have any conflicts of interest in regards to this case. |
|
| Authorship: We confirm that all of the authors had access to the data and had a significant role in writing and preparing this manuscript. |
© 2011
Publié par Elsevier Masson SAS.
Vol 124 - N° 8
P. e7-e8 - août 2011 Retour au numéro
Article précédent
- Acute Cerebrovascular Manifestation of Takayasu Arteritis
- Yannick Béjot, Grégory Couvreur, Frédéric Ricolfi, Guy-Victor Osseby, Alexandre Cochet, Maurice Giroud
- Is Migraine a Modifiable Risk Factor for Ischemic Stroke? Potentially Not
- Simona Sacco, Antonio Carolei
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?